Acute Respiratory Distress Syndrome

 

Acute Respiratory Distress Syndrome (ARDS) is also known as shock lung, diffuse alveolar damage, or acute lung injury.

 

Epidemiology

 

Severe acute lung injury is caused by toxic insults.

 

 

Signs and Symptoms

ARDS is characterized by the rapid onset of severe, life-threatening respiratory insufficiency (dyspnea and tachypnea), cyanosis, and

 

return to top

 

Diagnosis

Chest radiographs are intially normal but soon show diffuse alveolar infiltration and bilateral opacities. As this can mimic heart failure, clinical correlates are also required for diagnosis.

Severe arterial hypoxemia and decreased PaO2, with a PaO2/FiO2 ratio less than 200, refractory to oxygen therapy.

Pulmonary arterial wedge pressure (surrogate for left atrial pressure) is <18 mmHg, suggesting no clinical evidence of left heart failure.

Histologically, hyaline membranes are present

 

 

return to top

 

 

 

Pathophysiology

 

ARDS results from diffuse alveolar capillary damage. Alveolar flooding leads to loss of diffusion capacity, and type II pneumocytes become damaged.

During the acute phase, epithelial and endothelial injury lead to edema and hyaline membranes form.

 

During the organizing phase, alveolar collapse, fibroblast proliferation, and fibrosis occurs. Diffuse tissue destruction is not easily repaired, and scarring results.

 

IL-1 and TNF recruit neutrophils, and NF-kB-mediated genes are transcribed.

 

 

return to top

 

 

Causes and Risk Factors

ARDS has many causes:

 

infection

trauma and injury: fractures and fat emboli, burns, radiation

gas and chemical injury

multiple transfusions

disseminated intravascular coagulation

pancreatitis

uremia

cardiopulmonary bypass

hypersensitivitry reactions

idiopathic ARDS is referred to as acute interstitial pneumonia

 

 

return to top

 

Treatments

 

Positive expiratory pressure (PEP) keeps the airways open and keeps them from filling with fluids.

 

 

 

 

return to top

 

 

Course

Respiratory acidosis can develop.

Mortality rate is about 60%.

 

return to top

 

Patient Education

 

 

 

return to top

 

Community Resources

 

 

 

return to top

 

 

 

References